Trevi Therapeutics Inc (NQ: TRVI )

2.750 -0.140 (-4.84%)

Streaming Delayed Price Updated: 3:52 PM EDT, Jul 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Trevi Therapeutics Inc

Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast

January 25, 2023

Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),...

Via Newsfile

Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast

August 22, 2022

Phoenix, Arizona--(Newsfile Corp. - August 22, 2022) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),...

Via Newsfile

Exposures Product Safety

Traders News Source Senior Editor Mark Roberts Interviews Jennifer Good CEO of Trevi Therapeutics

July 14, 2022

NEW YORK, NY / ACCESSWIRE / July 14, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a...

From Traders News Source

Via AccessWire

5 Best Performing Micro-Cap Stocks Through the First Half of 2022

July 05, 2022

The first half of 2022 is finally in the books and it could not have come sooner. Major U.S. indices

Via Spotlight Growth

Topics Stocks

Exposures Fossil Fuels US Equities

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.